NCT06426407View on ClinicalTrials.gov

Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator

Not yet recruitingOBSERVATIONAL
Enrollment

48

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

June 30, 2027

Conditions
Shock, Septic
Interventions
DRUG

Vasopressin

Fixed dosage vasopressin ordered as an adjunctive vasopressor to norepinephrine

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT06426407 - Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator | Biotech Hunter | Biotech Hunter